Fundamentals screen · refreshed after the Nov 12, 2026 close
Highest profit margins: Healthcare
Large companies keeping the most of each dollar of revenue as profit. Net margin for the latest quarter: net income divided by revenue.
| # | Company | Price | Net margin | Gross margin | Revenue YoY | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | NRIXNurix TherapeuticsHealthcare | $15.60 | 81.7% | 100.0% | +8426.3% | $1.70B |
| 2 | PTGXProtagonist TherapeuticsHealthcare | $134.38 | 80.2% | 99.6% | +5723.6% | $8.77B |
| 3 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per shareHealthcare | $24.66 | 73.5% | 57.9% | +3.2% | $3.95B |
| 4 | BIO.BBio-Rad LaboratoriesHealthcare | $389.98 | 69.9% | 50.1% | +0.5% | $10.49B |
| 5 | BIOBio-Rad LaboratoriesHealthcare | $370.48 | 69.9% | 50.1% | +0.5% | $9.96B |
| 6 | ZYMEZymeworksHealthcare | $26.47 | 67.7% | 100.0% | +828.7% | $1.86B |
| 7 | IMAXImaxHealthcare | $47.89 | 65.2% | 72.4% | +63.7% | $2.64B |
| 8 | ETONEton PharmaceutcialsHealthcare | $61.45 | 60.9% | 76.5% | +157.9% | $1.77B |
| 9 | HALOHalozyme TherapeuticsHealthcare | $100.67 | 50.1% | 83.3% | +39.2% | $11.48B |
| 10 | KRYSKrystal BiotechHealthcare | $305.68 | 49.5% | 94.1% | +30.2% | $9.06B |
| 11 | PGENPrecigenHealthcare | $4.66 | 48.2% | 91.2% | +2437.6% | $1.67B |
| 12 | OMEROmerosHealthcare | $17.99 | 46.4% | 97.2% | — | $1.30B |
| 13 | LQDALiquidiaHealthcare | $58.12 | 43.5% | 93.3% | +1842.7% | $5.24B |
| 14 | COOThe Cooper CompaniesHealthcare | $62.19 | 40.6% | 66.8% | +0.6% | $11.83B |
| 15 | REGNRegeneron PharmaceuticalsHealthcare | $951.19 | 38.1% | 88.8% | +36.3% | $98.40B |
| 16 | AUPHAurinia PharmaceuticalsHealthcare | $16.21 | 37.9% | 90.1% | +13.9% | $2.17B |
| 17 | KLACKLAHealthcare | $157.30 | 37.4% | 61.9% | +28.9% | $204.96B |
| 18 | AMGNAmgenHealthcare | $467.06 | 37.3% | 73.1% | +8.5% | $252.64B |
| 19 | CORTCorcept TherapeuticsHealthcare | $73.71 | 37.2% | 98.6% | +64.0% | $7.97B |
| 20 | ADMAADMA BiologicsHealthcare | $13.24 | 35.4% | 70.8% | +5.1% | $2.94B |
| 21 | XNCRXencorHealthcare | $38.13 | 33.8% | 100.0% | +454.9% | $2.86B |
| 22 | EXELExelixisHealthcare | $69.84 | 33.1% | 96.0% | +10.2% | $17.04B |
| 23 | UTHRUnited TherapeuticsHealthcare | $593.31 | 31.1% | 88.1% | +4.1% | $25.27B |
| 24 | RMDResMedHealthcare | $238.89 | 29.6% | 61.5% | +5.9% | $33.60B |
| 25 | GILDGilead SciencesHealthcare | $167.95 | 29.3% | 81.1% | +6.8% | $208.31B |
| 26 | MRKMerck & Co.Healthcare | $146.95 | 28.0% | 73.0% | +4.7% | $362.27B |
| 27 | IRMDiRadimedHealthcare | $85.23 | 26.9% | 76.3% | +14.2% | $1.09B |
| 28 | LLYEli Lilly &Healthcare | $1,427.28 | 26.4% | 83.9% | +38.6% | $1.27T |
| 29 | IDXXIdexx LaboratoriesHealthcare | $698.02 | 26.1% | 62.9% | +9.9% | $54.99B |
| 30 | BMYBristol-Myers SquibbHealthcare | $62.32 | 25.6% | 71.3% | +5.7% | $127.39B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.